After huddling in our caves for a year – the world is coming to life again. That will be good for the economy, it will be good for everyone’s mental health, but most importantly it will likely mean a boom in innovation. The problem is that until the Trump Administration Read more…
Market Institute President Charles Sauer has a new piece in RealClear Policy on patent rights. The White House recently issued a patent waiver for Covid-19 vaccines. Here’s an excerpt of Sauer’s article: “President Biden recently made what the Wall Street Journal referred to as the worst single Presidential decision since Nixon’s Read more…
Market Institute President Charles Sauer has a new article up at the Washington Examiner on how the United States Patent and Trademark Office has empowered innovation the last 4 years. President Trump’s legacy will be something that is debated for years to come, but his administration did have some redeeming Read more…
The Market Institute President Charles Sauer has a new piece in the Washington Examiner looking at the White House’s newest proposed regulation on importing foreign prices controls for prescription drugs. Here is an excerpt: “On July 20, 1969, the United States landed on the moon. In November, a couple of Read more…
The Market Institute’s Charles Sauer is out with a new Op-ed in the Washington Examiner looking at legislation on “Surprise Billing.” In the midst of intense negotiations on a phase 4 coronavirus relief bill, a debate is brewing over the inclusion of a ‘fix’ to the issue of surprise billing. Read more…